Format

Send to

Choose Destination
Clin Biochem. 2000 Mar;33(2):107-13.

Induction of cytokine release by the acyl glucuronide of mycophenolic acid: a link to side effects?

Author information

1
Abteilung Klinische Chemie, Georg-August-Universität Göttingen, Göttingen, Germany. ewieland@med.uni-goettingen.de

Abstract

OBJECTIVES:

We have identified an acyl glucuronide (M-2) of the immunosuppressant mycophenolic acid (MPA). Acyl glucuronides have toxic potential and may contribute to drug toxicity. Whether acyl glucuronides are able to induce release of proinflammatory cytokines is unknown. Gastrointestinal disturbances have been observed during MPA therapy and may involve an inflammatory reaction. This study investigated whether M-2 can induce IL-6 and TNF-alpha release as well as gene expression of these cytokines in leukocytes.

DESIGN AND METHODS:

M-2 was produced by incubation of MPA with human liver microsomes. Human mononuclear leukocytes were incubated in the presence of M-2. Concentrations of IL-6 and TNF-alpha were measured by ELISA. Expression of mRNA was determined by quantitative RT-PCR.

RESULTS:

Incubation of 3 x 10(6) cells with M-2 resulted in a time and dose dependent release of cytokines, whereas MPA or its phenolic glucuronide MPAG were without effect. Cytokine liberation depended on mRNA induction. Response to M-2 showed much inter individual variability (30-fold for IL-6, 3-fold for TNF-alpha).

CONCLUSIONS:

If M-2 promotes release of cytokines in vivo, these may mediate some of the toxic actions of MPA.

PMID:
10751588
DOI:
10.1016/s0009-9120(99)00101-0
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center